Xtant Medical Holdings (XTNT) Cash from Operations (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Cash from Operations for 16 consecutive years, with $4.6 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Cash from Operations rose 368.45% year-over-year to $4.6 million in Q3 2025; TTM through Sep 2025 was $7.8 million, a 158.11% increase from a year earlier, with the FY2024 full-year figure at -$11.9 million, down 25.02% from the prior year.
• Cash from Operations was $4.6 million for Q3 2025 at Xtant Medical Holdings, up from $1.3 million in the prior quarter.
• Over five years, Cash from Operations peaked at $4.6 million in Q3 2025 and troughed at -$5.8 million in Q1 2024.
• A 5-year average of -$1.0 million and a median of -$1.0 million in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations jumped 955.87% in 2021 and tumbled 16906.67% in 2023, its largest moves.
• Over 5 years, Cash from Operations stood at $423000.0 in 2021, then sank by 640.9% to -$2.3 million in 2022, then surged by 60.01% to -$915000.0 in 2023, then jumped by 172.68% to $665000.0 in 2024, then jumped by 593.53% to $4.6 million in 2025.
• The last three Cash from Operations figures came in at $4.6 million (Q3 2025), $1.3 million (Q2 2025), and $1.3 million (Q1 2025), per Business Quant data.